Multiple Myeloma Knowledge Hub

text in different sizes and colors - oncology, treatment, health, diagnose, cancer, etc.

Hem/Onc Roundup: Improving CRC Detection with AI, Kidney Cancer Risk for Hispanic and Native...

This week on DocWire, editors spoke with Giovanni Di Napoli, President of Medtronic Gastrointestinal, about GI Genius, an intelligent endoscopy that uses artificial intelligence...
text in different sizes and colors - oncology, treatment, health, diagnose, cancer, etc.

Hem/Onc Roundup: Pfizer Pauses Myeloma Drug Trial; FDA to Ban Menthol Cigarettes

Multiple Myeloma Drug Trial Paused Due to Cases of Nerve Damage This week on DocWire, Pfizer Inc. paused enrollment in a phase 2 clinical trial...
text in different sizes and colors - oncology, treatment, health, diagnose, cancer, etc.

Hem/Onc Roundup: Gastric Cancer Immunotherapy, Cancer Vaccine Pilot Trial, and More

The U.S. Food and Drug Administration approved the first front-line immunotherapy for the treatment of gastric cancer. Nivolumab was approved in combination with fluoropyrimidine-...
FDA approved stamp

Melflufen Combination Approved for Heavily Pretreated Multiple Myeloma

On March 1, the U.S. Food and Drug Administration (FDA) granted accelerated approval to melphalan flufenamide (melflufen) in combination with dexamethasone for the treatment...
Sepsis-Associated Mortality Unlikely to be Prevented Through Enhanced Hospital-Based Care

Nearly Half of Patients with Multiple Myeloma Die in the Hospital

Findings presented at the ASH 2020 Annual Meeting & Exposition found that almost half of patients with multiple myeloma (MM) die in the hospital,...

Daratumumab Monotherapy Safe in Heavily Treated Relapsed or Refractory Multiple Myeloma

An early access treatment protocol (EAP) found that daratumumab monotherapy was safe in a population of patients with heavily treated relapsed or refractory multiple...
FDA Approves Nubeqa® for Prostate Cancer

Melflufen Combination Approved for Heavily Pretreated Multiple Myeloma

On March 1, the U.S. Food and Drug Administration (FDA) granted accelerated approval to melphalan flufenamide (melflufen) in combination with dexamethasone for the treatment...
Advertisement

Journal Reading List

Advertisement
Advertisement